NATIONAL RESEARCH CORP (NRC) Stock Fundamental Analysis
USA - NASDAQ:NRC - US6373722023 - Common Stock
15.89 USD
-0.02 (-0.13%)
15.89 USD
0 (0%)
NRC gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 101 industry peers in the Health Care Providers & Services industry. While NRC has a great profitability rating, there are quite some concerns on its financial health. NRC has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
NRC had positive earnings in the past year.
In the past year NRC had a positive cash flow from operations.
Each year in the past 5 years NRC has been profitable.
Each year in the past 5 years NRC had a positive operating cash flow.
1.2 Ratios
NRC has a better Return On Assets (12.68%) than 98.02% of its industry peers.
The Return On Equity of NRC (84.06%) is better than 99.01% of its industry peers.
NRC has a Return On Invested Capital of 20.28%. This is amongst the best in the industry. NRC outperforms 94.06% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for NRC is significantly above the industry average of 9.19%.
The 3 year average ROIC (37.15%) for NRC is well above the current ROIC(20.28%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 12.68% | ||
| ROE | 84.06% | ||
| ROIC | 20.28% |
ROA(3y)22.78%
ROA(5y)24%
ROE(3y)62.21%
ROE(5y)57.67%
ROIC(3y)37.15%
ROIC(5y)35.26%
1.3 Margins
Looking at the Profit Margin, with a value of 12.78%, NRC belongs to the top of the industry, outperforming 99.01% of the companies in the same industry.
In the last couple of years the Profit Margin of NRC has declined.
NRC has a better Operating Margin (19.88%) than 96.04% of its industry peers.
NRC's Operating Margin has declined in the last couple of years.
NRC has a Gross Margin of 60.31%. This is amongst the best in the industry. NRC outperforms 81.19% of its industry peers.
In the last couple of years the Gross Margin of NRC has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 19.88% | ||
| PM (TTM) | 12.78% | ||
| GM | 60.31% |
OM growth 3Y-10.18%
OM growth 5Y-5.95%
PM growth 3Y-11.83%
PM growth 5Y-7.25%
GM growth 3Y-2.32%
GM growth 5Y-1.11%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), NRC is creating value.
Compared to 1 year ago, NRC has less shares outstanding
The number of shares outstanding for NRC has been reduced compared to 5 years ago.
NRC has a worse debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 3.22 indicates that NRC is not in any danger for bankruptcy at the moment.
NRC has a Altman-Z score of 3.22. This is in the better half of the industry: NRC outperforms 66.34% of its industry peers.
NRC has a debt to FCF ratio of 8.73. This is a slightly negative value and a sign of low solvency as NRC would need 8.73 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 8.73, NRC is in line with its industry, outperforming 54.46% of the companies in the same industry.
A Debt/Equity ratio of 3.61 is on the high side and indicates that NRC has dependencies on debt financing.
NRC has a worse Debt to Equity ratio (3.61) than 77.23% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 3.61 | ||
| Debt/FCF | 8.73 | ||
| Altman-Z | 3.22 |
ROIC/WACC2.39
WACC8.47%
2.3 Liquidity
NRC has a Current Ratio of 0.70. This is a bad value and indicates that NRC is not financially healthy enough and could expect problems in meeting its short term obligations.
NRC has a Current ratio of 0.70. This is amonst the worse of the industry: NRC underperforms 86.14% of its industry peers.
NRC has a Quick Ratio of 0.70. This is a bad value and indicates that NRC is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.70, NRC is doing worse than 80.20% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.7 | ||
| Quick Ratio | 0.7 |
3. Growth
3.1 Past
The earnings per share for NRC have decreased strongly by -36.26% in the last year.
Measured over the past years, NRC shows a decrease in Earnings Per Share. The EPS has been decreasing by -3.70% on average per year.
Looking at the last year, NRC shows a decrease in Revenue. The Revenue has decreased by -4.08% in the last year.
The Revenue has been growing slightly by 2.25% on average over the past years.
EPS 1Y (TTM)-36.26%
EPS 3Y-10.59%
EPS 5Y-3.7%
EPS Q2Q%-101.82%
Revenue 1Y (TTM)-4.08%
Revenue growth 3Y-1.13%
Revenue growth 5Y2.25%
Sales Q2Q%-2.8%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 20.64, the valuation of NRC can be described as rather expensive.
Based on the Price/Earnings ratio, NRC is valued a bit cheaper than 67.33% of the companies in the same industry.
NRC's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.41.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.64 | ||
| Fwd PE | N/A |
4.2 Price Multiples
NRC's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. NRC is cheaper than 60.40% of the companies in the same industry.
NRC's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 39.52 | ||
| EV/EBITDA | 12.91 |
4.3 Compensation for Growth
NRC has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 2.96%, NRC has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 2.43, NRC pays a better dividend. On top of this NRC pays more dividend than 95.05% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.38, NRC pays a bit more dividend than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.96% |
5.2 History
The dividend of NRC decreases each year by -17.40%.
NRC has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)-17.4%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
NRC pays out 62.38% of its income as dividend. This is not a sustainable payout ratio.
The Dividend Rate of NRC has been decling, while earnings will also be declining. This means the current dividend is most likely not sustainable.
DP62.38%
EPS Next 2YN/A
EPS Next 3YN/A
15.89
-0.02 (-0.13%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners50.59%
Inst Owner Change0.23%
Ins Owners9.49%
Ins Owner Change10.89%
Market Cap366.42M
Analysts45
Price TargetN/A
Short Float %3.05%
Short Ratio3.83
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.96% |
Yearly Dividend0.48
Dividend Growth(5Y)-17.4%
DP62.38%
Div Incr Years0
Div Non Decr Years0
Ex-Date
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.64 | ||
| Fwd PE | N/A | ||
| P/S | 2.61 | ||
| P/FCF | 39.52 | ||
| P/OCF | 17.2 | ||
| P/B | 17.18 | ||
| P/tB | N/A | ||
| EV/EBITDA | 12.91 |
EPS(TTM)0.77
EY4.85%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.4
FCFY2.53%
OCF(TTM)0.92
OCFY5.82%
SpS6.08
BVpS0.92
TBVpS-2.05
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 12.68% | ||
| ROE | 84.06% | ||
| ROCE | 26.45% | ||
| ROIC | 20.28% | ||
| ROICexc | 21.34% | ||
| ROICexgc | 67.64% | ||
| OM | 19.88% | ||
| PM (TTM) | 12.78% | ||
| GM | 60.31% | ||
| FCFM | 6.61% |
ROA(3y)22.78%
ROA(5y)24%
ROE(3y)62.21%
ROE(5y)57.67%
ROIC(3y)37.15%
ROIC(5y)35.26%
ROICexc(3y)44.09%
ROICexc(5y)48.46%
ROICexgc(3y)273.96%
ROICexgc(5y)N/A
ROCE(3y)48.46%
ROCE(5y)46%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y-21.97%
ROICexc growth 5Y-12.09%
OM growth 3Y-10.18%
OM growth 5Y-5.95%
PM growth 3Y-11.83%
PM growth 5Y-7.25%
GM growth 3Y-2.32%
GM growth 5Y-1.11%
F-Score5
Asset Turnover0.99
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 3.61 | ||
| Debt/FCF | 8.73 | ||
| Debt/EBITDA | 2.25 | ||
| Cap/Depr | 189.66% | ||
| Cap/Sales | 8.58% | ||
| Interest Coverage | 9.03 | ||
| Cash Conversion | 62.23% | ||
| Profit Quality | 51.72% | ||
| Current Ratio | 0.7 | ||
| Quick Ratio | 0.7 | ||
| Altman-Z | 3.22 |
F-Score5
WACC8.47%
ROIC/WACC2.39
Cap/Depr(3y)236.79%
Cap/Depr(5y)169.97%
Cap/Sales(3y)9.3%
Cap/Sales(5y)6.92%
Profit Quality(3y)77.54%
Profit Quality(5y)88.07%
High Growth Momentum
Growth
EPS 1Y (TTM)-36.26%
EPS 3Y-10.59%
EPS 5Y-3.7%
EPS Q2Q%-101.82%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-4.08%
Revenue growth 3Y-1.13%
Revenue growth 5Y2.25%
Sales Q2Q%-2.8%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-29.67%
EBIT growth 3Y-11.19%
EBIT growth 5Y-3.83%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-56.39%
FCF growth 3Y-22.27%
FCF growth 5Y-11.96%
OCF growth 1Y-38.68%
OCF growth 3Y-9.26%
OCF growth 5Y-3.29%